Good Day BIO: Modernizing Medicare Part D

November 15, 2021
Congress is back—and drug pricing could be on the agenda. But here’s how we can modernize Medicare Part D without harming future cures. We also take a quick look at what happened during COP26 and President Biden’s pick for FDA Commissioner. (1,000 words, 5 minutes)
Biotechnology Innovation Organization (BIO)
 
 
 
 
BIO Beltway Report
Facebook
Twitter
LinkedIn
YouTube